Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

REGULATION of the EXTRACELLULAR MATRIX INTERACTOME by Trypanosoma cruzi.

Cardenas TC, Johnson CA, Pratap S, Nde PN, Furtak V, Kleshchenko YY, Lima MF, Villalta F.

Open Parasitol J. 2010;4:72-76.

2.

Regulation and use of the extracellular matrix by Trypanosoma cruzi during early infection.

Nde PN, Lima MF, Johnson CA, Pratap S, Villalta F.

Front Immunol. 2012 Nov 6;3:337. doi: 10.3389/fimmu.2012.00337. eCollection 2012.

3.

Gene network analysis during early infection of human coronary artery smooth muscle cells by Trypanosoma cruzi and Its gp83 ligand.

Nde PN, Johnson CA, Pratap S, Cardenas TC, Kleshchenko YY, Furtak VA, Simmons KJ, Lima MF, Villalta F.

Chem Biodivers. 2010 May;7(5):1051-64. doi: 10.1002/cbdv.200900320.

4.

Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection.

Nde PN, Simmons KJ, Kleshchenko YY, Pratap S, Lima MF, Villalta F.

Infect Immun. 2006 Mar;74(3):1643-8.

5.
6.

Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection.

Farrow AL, Rachakonda G, Gu L, Krendelchtchikova V, Nde PN, Pratap S, Lima MF, Villalta F, Matthews QL.

PLoS Negl Trop Dis. 2014 Aug 21;8(8):e3089. doi: 10.1371/journal.pntd.0003089. eCollection 2014 Aug.

7.
8.

A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts.

Mott GA, Costales JA, Burleigh BA.

PLoS One. 2011;6(9):e23482. doi: 10.1371/journal.pone.0023482. Epub 2011 Sep 8.

9.
10.

Thrombospondin-1 interacts with Trypanosoma cruzi surface calreticulin to enhance cellular infection.

Johnson CA, Kleshchenko YY, Ikejiani AO, Udoko AN, Cardenas TC, Pratap S, Duquette MA, Lima MF, Lawler J, Villalta F, Nde PN.

PLoS One. 2012;7(7):e40614. doi: 10.1371/journal.pone.0040614. Epub 2012 Jul 11.

11.

A ligand that Trypanosoma cruzi uses to bind to mammalian cells to initiate infection.

Villalta F, Smith CM, Ruiz-Ruano A, Lima MF.

FEBS Lett. 2001 Sep 21;505(3):383-8.

12.

Reevaluating the Trypanosoma cruzi proteomic map: The shotgun description of bloodstream trypomastigotes.

Brunoro GV, Caminha MA, Ferreira AT, Leprevost Fda V, Carvalho PC, Perales J, Valente RH, Menna-Barreto RF.

J Proteomics. 2015 Feb 6;115:58-65. doi: 10.1016/j.jprot.2014.12.003. Epub 2014 Dec 20.

PMID:
25534883
13.

Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection.

Augustine SA, Kleshchenko YY, Nde PN, Pratap S, Ager EA, Burns JM Jr, Lima MF, Villalta F.

Infect Immun. 2006 Jul;74(7):3922-9.

14.

Trypanosoma cruzi-cardiomyocyte interaction: role of fibronectin in the recognition process and extracellular matrix expression in vitro and in vivo.

Calvet CM, Meuser M, Almeida D, Meirelles MN, Pereira MC.

Exp Parasitol. 2004 May-Jun;107(1-2):20-30.

PMID:
15208034
15.
16.

Role of matrix metalloproteinases 2 and 9 in ex vivo Trypanosoma cruzi infection of human placental chorionic villi.

Castillo C, López-Muñoz R, Duaso J, Galanti N, Jaña F, Ferreira J, Cabrera G, Maya JD, Kemmerling U.

Placenta. 2012 Dec;33(12):991-7. doi: 10.1016/j.placenta.2012.10.004. Epub 2012 Oct 26.

PMID:
23107342
17.

Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction.

Madison MN, Kleshchenko YY, Nde PN, Simmons KJ, Lima MF, Villalta F.

Infect Immun. 2007 Oct;75(10):4780-91. Epub 2007 Jul 16.

18.

Trypanosoma cruzi infection: a continuous invader-host cell cross talk with participation of extracellular matrix and adhesion and chemoattractant molecules.

Marino AP, Silva AA, Pinho RT, Lannes-Vieira J.

Braz J Med Biol Res. 2003 Aug;36(8):1121-33. Epub 2003 Jul 23.

19.

Structures containing galectin-3 are recruited to the parasitophorous vacuole containing Trypanosoma cruzi in mouse peritoneal macrophages.

Reignault LC, Barrias ES, Soares Medeiros LC, de Souza W, de Carvalho TM.

Parasitol Res. 2014 Jun;113(6):2323-33. doi: 10.1007/s00436-014-3887-8. Epub 2014 Apr 24.

PMID:
24760627
20.

Epitope Capsid-Incorporation: New Effective Approach for Vaccine Development for Chagas Disease.

Matthews QL, Farrow AL, Rachakonda G, Gu L, Nde P, Krendelchtchikov A, Pratap S, Sakhare SS, Sabbaj S, Lima MF, Villalta F.

Pathog Immun. 2016 Fall-Winter;1(2):214-233.

Supplemental Content

Support Center